Effectiveness and Safety of the Colonoscopy With "Visualization" Balloon
A Randomized Controlled Trial to Evaluate Effectiveness and Safety of the Colonoscopy With the "Visualization" Balloon
Colonoscopy has become the "gold standard" in detection of colonic polyps and colon cancer. However, colonoscopy causes significant abdominal discomfort and abdominal pain during and after the procedure, requiring intravenous sedation and use of analgesics. The discomfort and pain are mostly caused by air insufflation and intubation difficulties during advancement of the colonoscope in order the reach the cecum.
Study Hypothesis: Use of the "Visualization" Balloon will facilitate advancement of the colonoscope and will eliminate the need for colonic distention with the air or CO2, which can shortened the length of the procedure, reduce patient's discomfort and can decrease amount of sedatives and analgesics used during colonoscopy.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
The goal of this study is to evaluate effectiveness and safety of a "Visualization" Balloon for performance of colonoscopy.
Our hypothesis is that, use of "Visualization" Balloon will decrease colonic distention, patient's discomfort, use of sedatives and analgetics during procedure and will simplify the performance of colonoscopy resulting in shortening of procedure time and increasing the rate of cecal intubation.
Specific aims of the study:
- To compare procedure time and effectiveness of the "Visualization" Balloon colonoscopy with traditional CO2-insufflation colonoscopy.
- To compare safety profiles between traditional CO2-insufflation colonoscopy and colonoscopy using the "Visualization" Balloon.
4 STUDY ENDPOINTS 4.1 Primary Outcome To compare the mean cecal intubation time achieved with "Visualization" Balloon colonoscopy, with the mean cecal intubation time achieved with standard colonoscopy using CO2 insufflation.
4.2 Secondary Outcomes
To compare "Visualization" Balloon colonoscopy with standard CO2-insufflation colonoscopy in regards of:
- Total amount of carbon dioxide (CO2) gas for colonic insufflation used during the procedure.
- Ease of colonoscope insertion.
- The length of the colonoscope when it reaches the cecum. 4 Colonoscope withdrawal time and total procedure time.
5. Cecal intubation rate. 6. Total dosage of analgesics and sedative during procedure. 7. Patient satisfaction: perceived pain and discomfort immediately after the procedure and in 24 hours post procedure.
8. Complications during and after colonoscopy. 9. Polyp detection rate.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Maryland
-
Baltimore, Maryland, Estados Unidos, 21202
- Mercy Medical Center
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- The patient is undergoing colonoscopy for colo-rectal cancer screening, polypectomy or for diagnostic workup.
- Subject is able to understand the risks and benefits of participating in the study and must be willing to sign and date the Informed Consent Form for this study approved by the Institutional Review Board (IRB.)
- Age from 17 to 90 years.
- Be willing and able to comply with the requirements of the protocol.
- Be willing to refrain from participating in any other investigational interventional study while enrolled in this study.
- Female subjects must have a negative pregnancy test within the last 24 hours timeline and have no intentions of becoming pregnant during participation in the study, or be sterilized.
Exclusion Criteria:
- Subjects with a history of previous colonic resection.
- Subjects with uncorrectable bleeding disorders (INR more than 1.5, platelet count less than 50,000).
- Subjects unwilling or unable to give written consent to participate in the investigation or unable to comply with the requirements of the protocol.
- Subjects with suspected colonic strictures potentially precluding complete colonoscopy.
- Subjects who received any experimental drug or device within the previous three months.
- Female subjects who were pregnant or lactating or were intending to become pregnant during the period of the study, or who would not use an adequate method of contraception (contraceptive pill, intra-uterine device) for the duration of the study.
- Subjects who possessed any psychological condition, or were under treatment for any condition which, in the opinion of the Investigator and/or consulting physicians(s), would constitute an unwarranted risk.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Diagnóstico
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Visualization balloon
Colonoscopy performed with the use of "Visualization" balloon
|
The "Visualization" Balloon is a disposable medical device that is used during the advancement of the colonoscope inside the colon.
The intended use of the "Visualization" Balloon is to help insertion of the colonoscope into the colon without the aid of gas (air or CO2) insufflation as with standard colonoscopy.
The "Visualization" Balloon is inserted through the biopsy channel of the colonoscope prior to the colonoscope introduction into the rectum.
The "Visualization" Balloon is an inflatable balloon that opens up the lumen of the gastrointestinal tract, thereby allowing the endoscopist to advance the endoscope inside and to view the gastrointestinal tract through the clear balloon.
|
|
Comparador Ativo: Traditional CO2-insufflation colonoscopy
Traditional colonoscopy performed with CO2 insufflation without "Visualization" balloon
|
Traditional colonoscopy performed with CO2 insufflation without "Visualization" balloon
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Cecal intubation time
Prazo: Immediately
|
Time required to reach cecum
|
Immediately
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Length of colonoscope when it reaches cecum
Prazo: Immediately
|
Total length of colonoscope when it reaches cecum
|
Immediately
|
|
Ease of colonoscope insertion
Prazo: Immediate
|
Easy of colonoscope insertion to cecum
|
Immediate
|
|
Dose of analgesics and sedatives used
Prazo: Immediately
|
Dose of analgesics and sedatives used during insertion and total dose for the entire procedure
|
Immediately
|
|
Patient satisfaction
Prazo: Immediately and in 24 hours
|
Patient satisfaction: perceived pain and discomfort immediately after the procedure and in 24 hours post procedure.
|
Immediately and in 24 hours
|
|
Total procedure time
Prazo: Immediately
|
Total time required to complete colonoscopy
|
Immediately
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Amount of carbon dioxide used
Prazo: Immediately
|
Total amount of carbon dioxide used during colonoscopy
|
Immediately
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Sergey V Kantsevoy, MD, PhD, Mercy Medical Center
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- VB-001
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Visualization balloon
-
Norwegian Department of Health and Social AffairsUniversity of OsloDesconhecido
-
Dalian UniversityConcluídoDoença arterial coronáriaChina
-
Integra LifeSciences CorporationAcclarentConcluídoSinusite CrônicaEstados Unidos
-
Boston Scientific CorporationConcluídoDoenças pancreáticas | Doenças das vias biliares | Doença HepáticaEstados Unidos, Índia, Hong Kong, China
-
Ceric SàrlEuropean Cardiovascular Research CenterRecrutamentoEstenose Aórtica Grave SintomáticaÁustria, Espanha, Sérvia, França, Suíça, Reino Unido, Alemanha, Itália, Hungria, Estônia, Polônia, Portugal, Romênia, Eslovênia
-
Integra LifeSciences CorporationAcclarentRescindido
-
Rhode Island HospitalRescindidoDoença pulmonar | Hérnia DiafragmáticaEstados Unidos
-
Prince of Wales Hospital, Shatin, Hong KongPeijia Medical Technology (Suzhou) Co., Ltd.RecrutamentoDoença cardíaca reumática | Calcificação do Anel MitralHong Kong
-
Airiver Medical, Inc.Ativo, não recrutandoRinossinusite CrônicaParaguai
-
Advanced Radiation Centers of New YorkAtivo, não recrutandoCâncer de próstataEstados Unidos